Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Support Care Cancer. 2013 Feb 28;21(7):2059–2066. doi: 10.1007/s00520-013-1766-y

Table 1.

Characteristics of participants who have and have not reported a recent fall

Total
(N=471)
Any fall
(N=51)
No fall
(N=378)
p
Gender, N (%) 0.310
  Male 125 (29.0) 18 (35.3) 107 (28.3)
  Female 306 (71.0) 33 (64.7) 271 (71.7)
Race, N (%) 0.100
  White 386 (82.0) 42 (82.4) 342 (90.5)
  Non-white 45 (9.6) 9 (17.7) 36 (9.5)
Hispanic, N (%) 0.710
  Yes 13 (3.0) 2 (3.9) 11 (2.9)
  No 415 (97.0) 49 (96.0) 364 (97.1)
Marital status, N (%) 0.325
  Married 305 (70.8) 33 (64.7) 270 (71.4)
  Widowed 41 (9.5) 8 (15.7) 33 (8.7)
  Other 85 (19.7) 10 (19.6) 75 (19.8)
Education, N (%) 0.668
  ≤HS 142 (33) 18 (35.3) 122 (32.3)
  ≥Partial college 289 (67) 33 (64.7) 256 (67.7)
Previous surgery, N (%) 0.174
  Yes 367 (85.2) 40 (78.4) 325 (86.0)
  No 64 (14.9) 11 (21.6) 53 (14.0)
Previous RT, N (%) 0.478
  Yes 203 (47.1) 25 (50.0) 176 (46.6)
  No 228 (52.9) 25 (50.0) 202 (53.4)
Breast cancer, N (%) 0.049*
  Yes 173 (40.1) 14 (27.5) 171 (41.5)
  No 258 (59.9) 37 (72.5) 258 (58.4)
Previous taxane treatment, N (%) 0.768
  Yes 253 (53.7) 26 (51.0) 201 (46.8)
  No 198 (46.3) 25 (49.0) 177 (53.2)
Age, mean (SD) 60.0 (10.3) 62.0 (9.6) 59.9 (10.2) 0.141
Months from end of chemotherapy, mean (SD) 15.5 (21.4) 21.7 (31.1) 14.7 (19.7) 0.127
Sensory, mean (SD) 21.8 (4.9) 24.3 (5.2) 21.5 (4.7) 0.0008*
Motor, mean (SD) 15.56 (4.7) 18.4 (5.6) 15.2 (4.5) 0.0003*

P value is based on χ2 test (categorical variables) or t test (continuous variables) between groups of participants who reported any falls or no fall HS high school, RT radiation therapy

*

p=0.05